Impaktované publikace
Kramarzova, K.; Stuchly, J.; Willasch, A.; Gruhn, B.; Schwarz, J.; Cermak, J.; Machova-Polakova, K.; Fuchs, O.; Stary, J.; Trka, J.; Boublikova, L.
Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences
[rok vydání 2012, impact factor 10.164 ]
Pribyl, M.; Hubackova, S.; Moudra, A.; Vancurova, M.; Polackova, H.; Stopka, T.; Jonasova, A.; Bokorova, R.; Fuchs, O.; et al.
Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes
[rok vydání 2020, impact factor 6.603 ]
Cmejlova, J.; Hildinger, M.; Cmejla, R.; Fuchs, O.; Zakova, D.; Baum, C.; Jelinek, J.
Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer
[rok vydání 2006, impact factor 5.293]
Hájková, H.; Fritz, M.H-Y.; Haškovec, C.; Schwarz, J.; Šálek, C.; Marková, J.; Krejčík, Z.; Dostálová Merkerová, M.; Kostečka, A.; Vostrý, M.; Fuchs, O.; Michalová, K.; Cetkovský, P.; Beneš, V.
CBFB - MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia
[rok vydání 2014, impact factor 4.812 ]
Brodská, B.; Otevřelová, P.; Šálek, C.; Fuchs, O.; Gašová, Z.; Kuželová, K.
High PD-L1 expression predicts for worse outcome of leukemia patients with concomitant NPM1 and FLT3 mutations
[rok vydání 2019, impact factor 4.556 ]
Stopka, T.; Zakova, D.; Fuchs, O.; Kubrova, O.; Blafkova, J.; Jelinek, J.; Necas, E.; Zivny, J.
Chromatin remodeling gene SMARCA5 is dysregulated in primitive hematopoietic cells of acute leukemia
[rok vydání 2006, impact factor 3.736]
Kuželová, K.; Brodská, B.; Fuchs, O.; Dobrovolná, M.; Soukup, P.; Cetkovský, P.
Altered HLA class I profile associated with type A/D nucleophosmin mutation points to possible anti-nucleophosmin immune response in acute myeloid leukemia
[rok vydání 2015, impact factor 3.057 ]
Hradilek, A.; Fuchs, O.; Neuwirt, J.
Inhibition of heme synthesis decreases transferrin receptor expression in mouse erythroleukemia cells
[rok vydání 2006, impact factor 3.020]
Fuchs, O.; Kostecka, A.; Provaznikova, D.; Krasna, B.; Brezinova, J.; Filkukova, J.; Kotlin, R.; Kouba, M.; Kobylka, P.; Neuwirtova, R.; Jonasova, A.; Caniga, M.; Schwarz, J.; Markova, J.; Maaloufova, J.; Sponerova, D.; Novakova, L.; Cermak, J.
Nature of frequent deletions in CEBPA
[rok vydání 2009, impact factor 2.901]
Lemež, P.; Gáliková, J.; Michalová, K.; Fuchs, O.; MacWhannell, A.; Zemanová, Z.; Březinová, J.; Černá, M.; Stejskal, J.
De novo acute myeloid leukemia involving only granulocyte-macrophage line in octogenarians leucocytes over 15 × 10⁹/L exhibit a favorable response to standard-dose induction chemotherapy
[rok vydání 2018, impact factor 2.850 ]
Kuželová, K.; Brodská, B.; Schetelig, J.; Röllig, C.; Ráčil, Z.; Stickel Walz, J.; Helbig, G.; Fuchs, O.; Vraná, M.; Pecherková, P.; Šálek, C.; Mayer, J.
Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin
[rok vydání 2018, impact factor 2.776 ]
Hájková, H.; Marková, J.; Haškovec, C.; Šárová, I.; Fuchs, O.; Kostečka, A.; Cetkovský, P.; Michalová, K.; Schwarz, J.
Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation
[rok vydání 2012, impact factor 2.764 ]
Fuchs, O.; Provaznikova, D.; Kocova, M.; Kostecka, A.; Cvekova, P.; Neuwirtova, R.; Kobylka, P.; Cermak, J.; Brezinova, J.; Schwarz, J.; Markova, J.; Salaj, P.; Klamova, H.; Maaloufova, J.; Lemez, P.; Novakova, L.; Benesova, K.
CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin´s lymphoma
[rok vydání 2008, impact factor 2.749]
Proteomic analysis of serum for identification of potential biomarkers predicting response of patients with refractory multiple myeloma to bortezomib-based therapy
[rok vydání 2017, impact factor 2.658 ]
Grebeňová, D.; Kuželová, K.; Fuchs, O.; Halada, P.; Havlíček, V.; Marinov, I.; Hrkal, Z.
Interferon-alpha suppresses proliferation of chronic myelogenous leukemia cells K562 by extending cell cycle S-phase without inducing apoptosis
[rok vydání 2006, impact factor 2.549]
Jonasova, A.; Bokorova, R.; Polak, J.; Vostry, M.; Kostecka, A.; Hajkova, H.; Neuwirtova, R.; Siskova, M.; Sponerova, D.; Cermak, J.; Mikulenkova, D.; Cervinek, L.; Brezinova, J.; Michalova, K.; Fuchs, O.
High level of full length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide
[rok vydání 2014, impact factor 2.544 ]
Neuwirtova, R.; Fuchs, O.; Holicka, M.; Vostry, M.; Kostecka, A.; Hajkova, H.; Jonasova, A.; Cermak, J.; Cmejla, R.; Pospisilova, D.; Belickova, M.; Siskova, M.; Hochova, I.; Vondrakova, J.; Sponerova, D.; Kadlckova, E.; Novakova, L.; Brezinova, J.; Michalova, K.
Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia
[rok vydání 2012, impact factor 2.396 ]
Grebeňová, D.; Kuželová, K.; Smetana, K.; Pluskalová, M.; Cajthamlová, H.; Marinov, I.; Fuchs, O.; Souček, J.; Jarolím, P.; Hrkal, Z.
Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells
[rok vydání 2006, impact factor 2.275]
Jonasova, A.; Neuwirtova, R.; Polackova, H.; Siskova, M.; Stopka, T.; Cmunt, E.; Belickova, M.; Moudra, A.; Minarik, L.; Fuchs, O.; Michalova, K.; Zemanova, Z.
Lenalidomide treatment in lower risk myelodysplastic syndromes: the experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients)
[rok vydání 2018, impact factor 2.066 ]
Fuchs, O.; Simakova, O.; Klener, P.; Cmejlova, J.; Zivny, J.; Zavadil, J.; Stopka, T.
Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4
[rok vydání 2006, impact factor 1.772]